Efficacy of a "mixed bacterial vaccine" in prophylaxis of acute respiratory infections: possible role of interferon.
D000257:Adenoviridae Infections / Q000517:prevention & control; D000907:Antibodies, Bacterial; D000917:Antibody Formation; D001428:Bacterial Vaccines / Q000008:administration & dosage / Q000009:adverse effects; D002986:Clinical Trials as Topic; D003139:Common Cold / Q000517:prevention & control; D006193:Haemophilus influenzae / Q000276:immunology; D006801:Humans; D007251:Influenza, Human / Q000517:prevention & control; D007275:Injections, Intravenous; D007372:Interferons / Q000096:biosynthesis* / Q000302:isolation & purification; D007711:Klebsiella pneumoniae / Q000276:immunology; D008213:Lymphocyte Activation; D008297:Male; D008875:Middle Aged; D009343:Neisseria / Q000276:immunology; D018184:Paramyxoviridae Infections / Q000517:prevention & control; D010919:Placebos; D012141:Respiratory Tract Infections / Q000517:prevention & control*; D013209:Staphylococcal Vaccines / Q000008:administration & dosage / Q000009:adverse effects; D013291:Streptococcus / Q000276:immunology; D013296:Streptococcus pneumoniae / Q000276:immunology
D000907:Antibodies, Bacterial; D001428:Bacterial Vaccines; D010919:Placebos; D013209:Staphylococcal Vaccines; D007372:Interferons